At Implicity, we help improve the patient care standard by offering an effective AI-based remote monitoring solution
Location: United States
Employees: 51-200
Total raised: $63M
Founded date: 2016
Investors 3
| Date | Name | Website |
| - | Karista Ve... | karista.vc |
| 24.03.2021 | Plug and P... | plugandpla... |
| 12.11.2022 | Credit Mut... | creditmutu... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 11.09.2026 | - | $40M | Iris Capit... |
| 28.04.2022 | Series A | $23M | - |
Mentions in press and media 13
| Date | Title | Description |
| 14.09.2026 | European tech weekly recap: Over €3.9B invested across 70+ deals | Last week, we tracked more than 70 tech funding deals worth over €3.9 billion and over 5 exits, M&A transactions, rumours, and related news stories across Europe. 📊 The top three industries that raised the most were artificial intellige... |
| 11.09.2026 | Implicity Secures $40M Funding | CAMBRIDGE, MA, Implicity, a global leader in AI-driven cardiac remote monitoring, has secured a $40 million funding round. >> Click here for more funding data on Implicity >> To export Implicity funding data to PDF and Excel, c... |
| 11.09.2025 | Redefining Cardiac Outcomes Through Independent Remote Monitoring Platforms | Arnaud Rosier, CEO of Implicity As healthcare continues its shift toward value-based, patient-centered care, remote monitoring (RM) has become a cornerstone in the management of chronic cardiac conditions. For patients with implantable card... |
| 01.09.2025 | Europe’s digital health innovators warn: “unite or fall behind” | Today, a coalition of 33 digital health organisations from across Europe, including industry associations and startups from France, Germany and other EU member states, has published a joint statement urging European decision-makers to estab... |
| 17.05.2024 | Implicity Launches FDA-approved Heart Failure Prediction Algorithm, SignalHF | What You Should Know: – Implicity, a leader in remote patient monitoring and cardiac data management, has received FDA 510(k) clearance for SignalHF1, a groundbreaking new algorithm within their remote monitoring solution. – SignalHF1 algor... |
| 26.03.2024 | Metyos raises €2.3M pre-seed to combat chronic kidney disease | Paris based medtech startup Metyos has raised €2.3 million in pre-seed funding to develop biosensors for the 800 million people affected by chronic kidney disease (CKD). Metyos’ biosensors take the form of a small patch that sticks to the s... |
| 03.03.2023 | Implicity Launches SMART on FHIR App to Optimize Interoperability & Workflow Efficiencies | What You Should Know: – Implicity, a leader in remote patient monitoring (RPM) and cardiac data management solutions, released a new SMART on FHIR application to improve interoperability and workflow efficiencies for providers. – The new ap... |
| 29.04.2022 | EIT Health-supported IMPLICITY raises €21M | IMPLICITY®, a leader in remote patient monitoring and cardiac data management solutions, announced yesterday that it has raised €21 million in Series A funding led by new investors: Crédit Mutuel Innovation and Bpifrance. IMPLICITY’s Europ... |
| 28.04.2022 | Implicity Raises $23M in Series A Funding | Implicity, a Cambridge, MA-based provider of a remote patient monitoring and cardiac data management solutions, raised $23M in Series A funding. The round was led by Crédit Mutuel Innovation and Bpifrance, with participation from BNP Pariba... |
| 23.07.2021 | Implicity Launches A Solution To Improve Remote Monitoring Of Heart Failure Patients | Company Signs Commercial Agreement with Bayer HealthCare SAS France to Accelerate Global Adoption and Improve Quality of Care for Heart Failure Patients Worldwide Implicity, a leader in remote patient monitoring software and cardiac data ma... |
Show more